June 2026 in “Mendeley Data” The "Hair Loss Therapeutics Drug Database" is a comprehensive resource detailing pharmacological agents for treating hair loss disorders such as androgenetic alopecia, alopecia areata, and pseudofolliculitis barbae. It includes information on each drug's chemical properties, pharmacological classification, mechanism of action, molecular target, pharmacokinetics, clinical efficacy, dosage regimens, safety profile, regulatory status, and therapeutic uses. The database is designed to aid food and drug companies in research, drug development, bioinformatics, QSAR modeling, clinical decision support, and education.
August 2011 in “SpringerReference” 6 citations
,
March 2017 in “Journal of the European Academy of Dermatology and Venereology” Identical twins with a rare KRT 86 gene mutation both have the hair disorder monilethrix.
July 2016 in “Hair transplant forum international” I'm unable to summarize the document because it cannot be parsed.
January 2014 in “Hair transplant forum international” I'm unable to summarize the document because it cannot be parsed.
March 2024 in “Residência Pediátrica” An infant developed excessive hair growth after a bone marrow transplant and cyclosporine treatment.
June 2023 in “Zenodo (CERN European Organization for Nuclear Research)” 2 citations
,
September 2016 in “Journal of Dermatological Science” Reduced TRPS1 leads to increased STAT3 and SOX9 in hair follicles, affecting hair growth.
8 citations
,
March 2023 in “British Journal of Dermatology” Next-generation sequencing greatly improves understanding and treatment of genetic hair disorders.
2 citations
,
January 1989 Tay syndrome is a unique genetic disorder causing skin, hair, and developmental issues.